Antipsychotic Drugs Market Size, Share & Industry Analysis, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, and Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, and Others), By Therapeutic Class (First Generation, Second Generation, and Third Generation), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 26, 2026 | Format: PDF | Report ID: FBI101390

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Psychiatric Disorders, By Key Countries/Regions
2. Analysis of the Cost and Burden of Mental Health Disorders
3. Overview of Current Advances in R&D for Antipsychotic Drugs
4. Pipeline Analysis, Key Players
5. Analysis: First Generation Antipsychotics vs. Third Generation Antipsychotics
6. Key Industry Developments, Mergers, Acquisitions, Etc.
7. New Product Launches
8. Impact of COVID-19 on Antipsychotic Drugs Market
Global Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Disease
  2. Canada
    1. By Disease
Europe Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
    1. By Disease
  2. U.K.
    1. By Disease
  3. France
    1. By Disease
  4. Italy
    1. By Disease
  5. Spain
    1. By Disease
  6. Scandinavia
    1. By Disease
  7. Rest of Europe
    1. By Disease
Asia Pacific Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
    1. By Disease
  2. India
    1. By Disease
  3. Japan
    1. By Disease
  4. Australia
    1. By Disease
  5. Southeast Asia
    1. By Disease
  6. Rest of Asia Pacific
    1. By Disease
Latin America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
    1. By Disease
  2. Mexico
    1. By Disease
  3. Rest of Latin America
    1. By Disease
Middle East & Africa Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
    1. By Disease
  2. South Africa
    1. By Disease
  3. Rest of Middle East & Africa
    1. By Disease
Competitive Analysis
1. Global Market Share Analysis (2026)
2. Company Profiles
  1. Otsuka Pharmaceutical Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Teva Pharmaceutical Industries Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Dr. Reddy’s Laboratories Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. H. Lundbeck A/S
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. ALLERGAN (AbbVie, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Eli Lilly and Company
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Alkermes plc
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Bristol-Myers Squibb Company
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Sumitomo Dainippon Pharma Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Psychiatric Disorders, By Key Countries/Regions
2. Analysis of the Cost and Burden of Mental Health Disorders
3. Overview of Current Advances in R&D for Antipsychotic Drugs
4. Pipeline Analysis, Key Players
5. Analysis: First Generation Antipsychotics vs. Third Generation Antipsychotics
6. Key Industry Developments, Mergers, Acquisitions, Etc.
7. New Product Launches
8. Impact of COVID-19 on Antipsychotic Drugs Market
Global Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
North America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
    1. By Disease
  2. Canada
    1. By Disease
Europe Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Germany
    1. By Disease
  2. U.K.
    1. By Disease
  3. France
    1. By Disease
  4. Italy
    1. By Disease
  5. Spain
    1. By Disease
  6. Scandinavia
    1. By Disease
  7. Rest of Europe
    1. By Disease
Asia Pacific Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. China
    1. By Disease
  2. India
    1. By Disease
  3. Japan
    1. By Disease
  4. Australia
    1. By Disease
  5. Southeast Asia
    1. By Disease
  6. Rest of Asia Pacific
    1. By Disease
Latin America Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. Brazil
    1. By Disease
  2. Mexico
    1. By Disease
  3. Rest of Latin America
    1. By Disease
Middle East & Africa Antipsychotic Drugs Market Analysis, Insights and Forecast, 2021-2034
1. Market Analysis, Insights and Forecast– By Disease
  1. Schizophrenia
  2. Bipolar Disorder
  3. Unipolar Depression
  4. Dementia
  5. Others
2. Market Analysis, Insights and Forecast– By Drug
  1. Risperidone
  2. Quetiapine
  3. Olanzapine
  4. Aripiprazole
  5. Brexpiprazole
  6. Paliperidone Palmitate
  7. Others
3. Market Analysis, Insights and Forecast – By Therapeutic Class
  1. First Generation
  2. Second Generation
  3. Third Generation
4. Market Analysis, Insights and Forecast – By Distribution Channel
  1. Hospital Pharmacies
  2. Drug Stores & Retail Pharmacies
  3. Online Pharmacies
5. Market Analysis, Insights and Forecast – By Country/ Sub-Region
  1. GCC
    1. By Disease
  2. South Africa
    1. By Disease
  3. Rest of Middle East & Africa
    1. By Disease
Competitive Analysis
1. Global Market Share Analysis (2026)
2. Company Profiles
  1. Otsuka Pharmaceutical Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  2. Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  3. Teva Pharmaceutical Industries Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  4. Dr. Reddy’s Laboratories Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  5. H. Lundbeck A/S
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  6. ALLERGAN (AbbVie, Inc.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  7. Eli Lilly and Company
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  8. Alkermes plc
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  9. Bristol-Myers Squibb Company
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)
  10. Sumitomo Dainippon Pharma Co., Ltd.
    1. Overview
    2. Products & Services
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. Financials (Based on Availability)

Read Less

List of Figures

Figure 01: Global Antipsychotic Drugs Market Value Share (%), By Disease, 2026 & 2034

Figure 02: Global Antipsychotic Drugs Market Value Share (%), By Drug, 2026 & 2034

Figure 03: Global Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2026 & 2034

Figure 04: Global Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2026 & 2034

Figure 05: Global Antipsychotic Drugs Market Value Share (%), By Region, 2026 & 2034

Figure 06: North America Antipsychotic Drugs Market Value (USD billion), By Disease, 2026 & 2034

Figure 07: North America Antipsychotic Drugs Market Value Share (%), By Disease, 2026

Figure 08: North America Antipsychotic Drugs Market Value (USD billion), By Drug, 2026 & 2034

Figure 09: North America Antipsychotic Drugs Market Value Share (%), By Drug, 2026

Figure 10: North America Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2026 & 2034

Figure 11: North America Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2026

Figure 12: North America Antipsychotic Drugs Market Value (USD billion), By Distribution Channel, 2026 & 2034

Figure 13: North America Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2026

Figure 14: North America Antipsychotic Drugs Market Value (USD billion), By Country, 2026 & 2034

Figure 15: North America Antipsychotic Drugs Market Value Share (%), By Country, 2026

Figure 16: Europe Antipsychotic Drugs Market Value (USD billion), By Disease, 2026 & 2034

Figure 17: Europe Antipsychotic Drugs Market Value Share (%), By Disease, 2026

Figure 18: Europe Antipsychotic Drugs Market Value (USD billion), By Drug, 2026 & 2034

Figure 19: Europe Antipsychotic Drugs Market Value Share (%), By Drug, 2026

Figure 20: Europe Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2026 & 2034

Figure 21: Europe Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2026

Figure 22: Europe Antipsychotic Drugs Market Value (USD billion), By Distribution Channel, 2026 & 2034

Figure 23: Europe Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2026 & 2034

Figure 24: Europe Antipsychotic Drugs Market Value (USD billion), By Country/Sub-region, 2026 & 2034

Figure 25: Europe Antipsychotic Drugs Market Value Share (%), By Country/Sub-region, 2026

Figure 26: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Disease, 2026 & 2034

Figure 27: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Disease, 2026

Figure 28: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Drug, 2026 & 2034

Figure 29: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Drug, 2026

Figure 30: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2026 & 2034

Figure 31: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2026

Figure 32: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Distribution Channel, 2026 & 2034

Figure 33: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2026

Figure 34: Asia Pacific Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 35: Asia Pacific Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2026

Figure 36: Latin America Antipsychotic Drugs Market Value (USD billion), By Disease, 2026 & 2034

Figure 37: Latin America Antipsychotic Drugs Market Value Share (%), By Disease, 2026

Figure 38: Latin America Antipsychotic Drugs Market Value (USD billion), By Drug, 2026 & 2034

Figure 39: Latin America Antipsychotic Drugs Market Value Share (%), By Drug, 2026

Figure 40: Latin America Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2026 & 2034

Figure 41: Latin America Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2026

Figure 42: Latin America Antipsychotic Drugs Market Value (USD billion), By Distribution Channel, 2026 & 2034

Figure 43: Latin America Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2026

Figure 44: Latin America Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 45: Latin America Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2026

Figure 46: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Disease, 2026 & 2034

Figure 47: Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Disease, 2026

Figure 48: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Drug, 2026 & 2034

Figure 49: Middle East & Africa Antipsychotic Drugs Market Value Share (%),

Figure 50: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Therapeutic Class, 2026 & 2034

Figure 51: Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Therapeutic Class, 2026

Figure 52: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Distribution Channel 2026 & 2034

Figure 53: Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Distribution Channel, 2026

Figure 54: Middle East & Africa Antipsychotic Drugs Market Value (USD billion), By Country/ Sub-region, 2026 & 2034

Figure 55: Middle East & Africa Antipsychotic Drugs Market Value Share (%), By Country/ Sub-region, 2026

Figure 56: Global Antipsychotic Drugs Market Share Analysis, By Company, 2026

List of Tables

Table 01: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 02: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2021–2034

Table 03: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2021–2034

Table 04: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 05: Global Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Region, 2021–2034

Table 06: North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 07: North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2021–2034

Table 08: North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2021–2034

Table 09: North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 10: North America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 11: U.S. Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 12: Canada Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 13: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 14: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2021–2034

Table 15: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2021–2034

Table 16: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 17: Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 18: Germany Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 19: U.K. Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 20: France Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 21: Italy Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 22: Spain Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 23: Scandinavia Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 24: Rest of Europe Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 25: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 26: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2021–2034

Table 27: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2021–2034

Table 28: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 29: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 30: Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 31: China Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 32: India Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 33: Japan Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 34: Australia Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 35: South East Asia Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 36: Rest of Asia Pacific Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 37: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 38: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2021–2034

Table 39: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2021–2034

Table 40: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 41: Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 42: Brazil Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 43: Mexico Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 44: Rest of Latin America Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 45: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 46: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Drug, 2021–2034

Table 47: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Therapeutic Class, 2021–2034

Table 48: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Distribution Channel, 2021–2034

Table 49: Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 50: South Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 51: GCC Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

Table 52: Rest of Middle East & Africa Antipsychotic Drugs Market Revenue (USD billion) Forecast, By Disease, 2021–2034

STUDY PERIOD: 2021-2034
BASE YEAR: 2025
HISTORICAL DATA: 2021-2024
NO OF PAGES: 195

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com